Inventurus Knowledge Solutions Limited (IKS) has announced an additional investment of USD 14.5 million (approx. ₹121 crore) in its wholly owned US-based subsidiary, Inventurus Knowledge Solutions Inc. The move, disclosed to stock exchanges on April 22, 2025, is aimed at supporting the subsidiary’s working capital requirements.
IKS Inc., incorporated in Delaware, United States, provides a care enablement platform offering technology-enabled solutions for healthcare providers. The company plays a pivotal role in assisting U.S.-based healthcare service providers to deliver efficient, safer, and cost-effective care.
The investment has been made through a cash consideration, with the company subscribing to 23,097 equity shares at USD 627.81 per share. Despite the infusion, the shareholding of Inventurus Knowledge Solutions Limited in IKS Inc. remains unchanged, as the subsidiary is already fully owned.
As per the disclosure, IKS Inc. reported revenue from operations of ₹7,027.85 million in FY24, reflecting continued growth from ₹6,054.66 million in FY23 and ₹4,745.92 million in FY22. The company continues to maintain its strong presence in the U.S. healthcare technology space.
The investment is expected to be completed on or before May 31, 2025, and no regulatory approvals are required for the transaction.
This strategic funding aligns with the company’s long-term focus on strengthening its global operations and enhancing the capabilities of its technology-driven care solutions.
